OncoPro Prostate Cancer Screen Test
Short Name: OncoPro Prostate Cancer Screen
Also known as: OncoPro PSA Cancer Screen, Prostate Cancer Screening Panel, PSA Gray Zone Discrimination Test
OncoPro Prostate Cancer Screen Test test available at DNA Labs India for ₹28,080. Uses Extraction, Staining on Whole Blood samples. Results in Results are typically available within 21 working days from the date of sample receipt at the laboratory. Results will be accessible via the DNA Labs India online portal, email, or WhatsApp.. Free home collection in 300+ cities across India.
🩺 Medically Reviewed By
Dr Pasupathy Arumugam
Consultant Pathologist · Reg: 21521
Last reviewed: September 7, 2026
Overview
The purpose of the OncoPro Prostate Cancer Screen test is to assist physicians in evaluating patients whose total PSA levels are in the gray zone (4–10 ng/mL). By providing additional biochemical discrimination, this test helps determine whether a prostate biopsy is necessary, thereby reducing the rate of unnecessary biopsies while maintaining clinical sensitivity for detecting clinically significant prostate cancer.
- Test Code
- 34
- Price
- ₹28,080
- Sample Type
- Whole Blood
- Result Time
- Results are typically available within 21 working days from the date of sample receipt at the laboratory. Results will be accessible via the DNA Labs India online portal, email, or WhatsApp.
- Fasting Required
- No
- Method
- Extraction, Staining
Sample Collection
Complete the OncoPro Prostate Cancer Screen Clinical Information Form (Form 30) prior to sample collection. Avoid vigorous exercise, cycling, or sexual activity for at least 48 hours before the test. Inform your physician about any medications you are currently taking. No fasting is required.
Method: Venipuncture
Laboratory Analysis
A trained phlebotomist will collect 8 mL of whole blood via venipuncture into a Lavender Top (EDTA) tube from the DNA Labs India sample collection kit. The preservative supplied in the kit must be added to the EDTA tube using a syringe and needle as per the kit instructions.
Report Delivery
The sample must be shipped immediately at a temperature of 18–22°C. Do not refrigerate or freeze the sample. Mild bruising or soreness at the puncture site is normal and should resolve within a day.
Timeline: Results are typically available within 21 working days from the date of sample receipt at the laboratory. Results will be accessible via the DNA Labs India online portal, email, or WhatsApp.
Patient Instructions
About This Test
Who Should Get This Test
The purpose of the OncoPro Prostate Cancer Screen test is to assist physicians in evaluating patients whose total PSA levels are in the gray zone (4–10 ng/mL). By providing additional biochemical discrimination, this test helps determine whether a prostate biopsy is necessary, thereby reducing the rate of unnecessary biopsies while maintaining clinical sensitivity for detecting clinically significant prostate cancer.
How to Prepare
- Complete the mandatory OncoPro Prostate Cancer Screen Clinical Information Form (Form 30)
- Collect 8 mL whole blood in the 1 Lavender Top (EDTA) tube provided in the sample collection kit
- Add the preservative supplied in the kit to the EDTA tube using a syringe and needle
- Ship the sample immediately at 18–22°C
- Do NOT refrigerate or freeze the sample at any point
- Avoid vigorous exercise or sexual activity for 48 hours prior to collection
Doctor's Notes
Reviewed by Dr Pasupathy Arumugam — MBBS, MD (Pathology) · Reg. No. 21521
"Prostate cancer remains one of the most commonly diagnosed cancers among men globally. The OncoPro Prostate Cancer Screen test is a valuable adjunct when total PSA falls in the gray zone of 4–10 ng/mL. It helps clinicians decide whether a prostate biopsy is warranted, potentially reducing unnecessary invasive procedures while ensuring that significant cancers are not missed. Men with a family history of prostate cancer, those over 50, or those with African ancestry should discuss screening options with their physician."
Last medically reviewed: September 7, 2026
Test Parameters & Specifications
Sample Stability
- Sample refrigerated or frozen
- Missing or incomplete OncoPro Prostate Cancer Screen Clinical Information Form (Form 30)
- Sample collected in wrong tube type (non-EDTA)
- Insufficient sample volume (less than 8 mL)
- Sample received beyond 72 hours at room temperature
- Preservative not added to the EDTA tube
Understanding Your Results
The test suggests a lower likelihood of clinically significant prostate cancer. Your physician may recommend continued PSA monitoring at regular intervals rather than immediate biopsy.
May help avoid unnecessary prostate biopsies while maintaining appropriate clinical surveillance.
The result does not clearly indicate low or high probability. Additional clinical evaluation, repeat testing, or alternative diagnostic methods may be recommended.
Physician discretion is advised with potential for repeat screening or supplementary imaging such as multiparametric MRI.
The test suggests a higher likelihood of prostate cancer. Your physician is likely to recommend a prostate biopsy for definitive histopathological diagnosis.
Prompt follow-up with an oncologist or urologist is strongly recommended for timely diagnosis and treatment planning.
Consult your physician or oncologist if your PSA levels fall in the 4–10 ng/mL range, if you experience urinary symptoms such as frequent urination (especially at night), difficulty starting or stopping urination, weak urine flow, blood in urine or semen, or pelvic pain. Additionally, men over 50, those with a family history of prostate cancer, or those of African descent should discuss screening with their healthcare provider.
Limitations
- ⚠This test is a screening and decision-support tool; it is not a definitive diagnostic test for prostate cancer
- ⚠A prostate biopsy remains the gold standard for confirming prostate cancer diagnosis
- ⚠Results must be interpreted by a qualified physician in the context of clinical history and other investigations
- ⚠The test is validated for use in patients with total PSA in the 4–10 ng/mL gray zone range
- ⚠Sample handling deviations (e.g., refrigeration or freezing) may compromise results
Risks & Considerations
- ●Mild pain or bruising at the blood draw site
- ●Slight risk of infection at the puncture site
- ●Fainting or lightheadedness during blood draw (rare)
- ●False-positive or false-negative results may occur; confirmatory testing may be needed
Interfering Factors
- ●Recent digital rectal examination (DRE) may transiently elevate PSA levels
- ●Prostatitis or urinary tract infection can raise PSA
- ●Recent prostate biopsy may affect results
- ●Certain medications such as 5-alpha reductase inhibitors may lower PSA levels
- ●Vigorous physical activity or sexual activity within 48 hours prior to sample collection
Compare With Similar Tests
| Test | OncoPro Prostate Cancer Screen Test | Total PSA Test | Free PSA (fPSA) Test | Prostate Biopsy | Multiparametric MRI (mpMRI) of Prostate |
|---|---|---|---|---|---|
| Comparison | OncoPro Prostate Cancer Screen Test | The Total PSA test measures the overall level of PSA in blood. The OncoPro test goes further by providing cancer discrimination in the gray zone (4–10 ng/mL) where Total PSA alone is inconclusive. | The Free PSA test measures the unbound fraction of PSA. A lower free-to-total PSA ratio may suggest cancer. The OncoPro test uses extraction and staining methodology as a complementary approach. | A biopsy is the gold standard for confirming prostate cancer. The OncoPro test helps decide if biopsy is needed, potentially reducing unnecessary invasive procedures. | mpMRI provides detailed imaging of the prostate and can detect suspicious lesions. The OncoPro test is a blood-based alternative that provides biochemical discrimination without imaging. |
Frequently Asked Questions
What is the OncoPro Prostate Cancer Screen test?
What does the OncoPro test measure?
Who should consider taking the OncoPro Prostate Cancer Screen test?
What is the cost of the OncoPro Prostate Cancer Screen test?
What sample is required for the test?
How long does it take to get results?
Is fasting required for the OncoPro test?
What is the PSA gray zone and why does it matter?
Can the OncoPro test replace a prostate biopsy?
Is the OncoPro test the same as a standard PSA test?
Does DNA Labs India offer home sample collection for this test?
What should I do if my OncoPro test result indicates a high probability of cancer?
Related Tests
OncoPro Pan Cancer Monitor Test
₹29,250CAN Assist Breast Test
₹76,000Chromosome Analysis for Hematologic Malignancy Test
₹5,000FISH - Ewing Sarcoma (EWS) 22q12 (EWSR1) Rearrangement Test
₹8,500FISH - Synovial Sarcoma (SS18 / SYT) 18q11.2 Gene Rearrangement Test
₹12,000Hepatocellular Carcinoma (HCC) Panel Test
₹5,500Reference Laboratory Services
We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.
Your Data Privacy
Your medical data is protected under Indian law.
✓ Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.
✓ DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.
Book Your Test
Enter your details and we'll connect you within 15 minutes.